Clinical Trial

Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion

Recruiting
View on ClinicalTrials.gov →
Summary
Endovascular therapy (EVT) added on best medical management is currently recommended in acute large vascular occlusion (LVO) stroke patients with National Institutes of Health Stroke Scale (NIHSS) score \>5. Thus, a sizeable fraction of patients with a minor stroke that do not undergo cerebrovascular screening may experience an early neurological deterioration (END) due to LVO, possibly leading to poor long-term functional outcome. However, whether these patients may still benefit from a rescue EVT is unknown, especially in a late window (\>24 hours). In this study, the investigators assume that best medical management plus EVT might be superior than best medical management alone in a late window for minor stroke patients who have experienced an LVO and END. The primary objective of the study was to establish the safety and efficacy of EVT in a late window for minor stroke patients in the anterior circulation who experienced an LVO and END.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2023-11-24; most recent amendment 2026-04-27.
Status change: Not Yet Recruiting → Recruiting 2024-01-04
Trial Details
NCT Number NCT06155032
Lead Sponsor First Affiliated Hospital of Wannan Medical College
Collaborators: The First Affiliated Hospital of Anhui Medical University, Xiangtan Central Hospital, The First Affiliated Hospital of Hainan Medical University, Huang Shan People's Hospital, Fuyang people's hospital, Linyi People's Hospital, Jiujiang No.1 People's Hospital, Taihe Hospital
Conditions Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive
Enrollment 272 participants
Start Date 2024-01-04
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-30